Oncology News | pharmaphorum

News

BI drug named Promising Innovative Medicine in mesothelioma

Boehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for one of its drugs.

News

Novartis taking aim at Pfizer with new use for breast cancer...

FDA grants Breakthrough Therapy for Kisqali in premenopausal women.

News

NICE to reassess Pfizer blood cancer drug

Company successfully appealed against rejection last summer

News

Merck and Pfizer’s immunotherapy combination gains Breakthro...

Merck and Pfizer have received a major boost to their immune-oncology alliance with a second FDA Breakthrough Therapy Designation for Bavencio, this time in combination with Pfizer’s Inlyta

News

Janssen jumps into CAR-T field with China’s Legend Biotech

J&J has struck a deal with Chinese biotech company Genscript, giving it entry to the global market for CAR-T therapies.

News

Roche pays $1.7 billion for cancer specialist Ignyta

Roche is to bolster its cancer pipeline with the $1.7 billion acquisition of Ignyta.

BI drug named Promising Innovative Medicine in mesothelioma

Novartis taking aim at Pfizer with new use for breast cancer...

NICE to reassess Pfizer blood cancer drug

Merck and Pfizer’s immunotherapy combination gains Breakthro...

Janssen jumps into CAR-T field with China’s Legend Biotech

Roche pays $1.7 billion for cancer specialist Ignyta

Pfizer targets $2.5bn more in cost savings

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks